Cipher Pharmaceuticals

Cipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products.


Notice of Cipher Pharmaceuticals Q4 and Year-End 2017 Conference Call

Cipher Pharmaceuticals and Italmex Pharma Announce Exclusive Distribution Agreement for Isotretinoin Product in Mexico


Wednesday, February 28, 2018
8:30 am ET

Q4 and Year-end 2017 Results
Conference Call/Audio Webcast
647-427-7450 or 1-888-231-8191
Audio Webcast

Q3 2017 Results
Audio Webcast Replay
Audio Webcast


Patient access to our innovative products is important to Cipher.

Healthcare Professionals

Customer service drives all we do to help you make a difference in the lives of your patients.


Cipher is actively seeking to acquire or license dermatology products and candidates.